Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Revenue

Clearside Biomedical had revenue of $1.04M in the quarter ending September 30, 2024, with 20.84% growth. This brings the company's revenue in the last twelve months to $7.70M, up 248.39% year-over-year. In the year 2023, Clearside Biomedical had annual revenue of $8.23M with 519.89% growth.

• Revenue (ttm): $7.70M
• Revenue Growth: +248.39%
• P/S Ratio: 8.50
• Revenue / Employee: $256,767
• Employees: 30
• Market Cap: 71.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.23M	6.90M	519.89%
Dec 31, 2022	1.33M	-28.25M	-95.51%
Dec 31, 2021	29.58M	21.68M	274.65%
Dec 31, 2020	7.89M	5.72M	263.28%
Dec 31, 2019	2.17M	2.14M	7,143.33%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.